Skip to main content

ArnoldIn a recent MedCity News article, Renée Arnold, entrepreneur-in-residence at BioHealth Innovation and the National Institutes of Health, emphasizes the critical importance of early planning for reimbursement strategies in digital health startups. She discusses the common misconception that securing a reimbursement code is the final hurdle, when in reality, startups must ensure insurers will cover their product and that the payment aligns with their pricing model. Learn more about why startups need to integrate reimbursement planning early in their journey and avoid potential setbacks post-FDA approval.

Why Digital Health Startups Should Start Thinking About Their Reimbursement Pathway Earlier

By Katie Adams on September 10, 2024 – Some of the most challenging yet most important processes for digital health startups to navigate are those related to reimbursement and coding.

“People think, ‘Oh, I’ve got a code. I’m great. I can just go to the market and I’m going to get all the money.’ But it doesn’t work that way. You have to make sure that the insurer will cover you with that code and that the payment is commensurate with what you’d like the price to be,” said Renée Arnold, entrepreneur-in-residence at BioHealth Innovation and the National Institutes of Health, during a recent conference.

She made these remarks last week during a session at the Heart Rhythm Society’s HRX conference in Atlanta.

Click here to read the entire article.

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.